[Remote] Jr. Clinical Trials Data Specialist at Tempus

Illinois, United States

Apply Now

Not SpecifiedCompensation

Entry Level & New Grad, Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Precision MedicineIndustries

Skills

Key technologies and capabilities for this role

clinical trial matchingworkflow managementclinical reportingdata synthesishematologyoncologycritical evaluation of clinical trialsGeneticsMolecular GeneticsCancer BiologyBiological Sciencescritical thinkingproblem-solvingdetail-oriented

Questions & Answers

Common questions about this position

What is the salary range for the Jr. Clinical Trials Data Specialist position?

The expected salary range is $46,000 - $50,000 for the role performed from Illinois, though it may vary for other locations like California, Colorado, or New York, and actual salary depends on qualifications and experience.

What benefits does Tempus offer for this position?

Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.

Is this a remote position, or is there a location requirement?

This information is not specified in the job description.

What are the required qualifications for this role?

Candidates need a Bachelor's or Master's degree in Genetics, Molecular Genetics, Cancer Biology, or Biological Sciences, along with strong communication skills, critical thinking, problem-solving, detail-orientation, and the ability to work independently and collaboratively in a fast-paced environment.

What makes a strong candidate for this position at Tempus?

A strong candidate will have the required degree in a relevant biological science field, preferred experience reviewing hematology/oncology records or evaluating clinical trials, basic knowledge of generative AI, and a passion for precision medicine in a collaborative, fast-paced team.

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free